Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr Greish graduated from the Faculty of Medicine, Suez Canal University, Egypt in 1992. He received his master degree of clinical oncology in 1997. Then he moved to Japan from 1999 to early 2008 to join the lab of Professor Hiroshi Maeda, a world leader in the field of anticancer Nanomedicine. Initially as a PhD student, then as JSPS post-doctoral fellow. Along with Professor Maeda they both developed an affordable platform Nanotechnology miceller system for targeting anticancer drugs specifically to solid tumours. In 2008 he moved to the United States to join the department of pharmaceutics and pharmaceutical chemistry department, University of Utah, as Research Assistant Professor. His contribution to the research field of anticancer drug delivery were recognized by the Controlled Release Society (CRS), by awarding him the CRS Postdoctoral Achievement award in 2008 and in 2010 by electing him as a CRC College of Fellows in 2010.
Dr Greish's areas of interest span the formulation and characterization of different advanced drug delivery systems, anticancer drug discovery/development, tumour vascular biology and animal tumour models.
Hayley Nehoff, Neha N. Parayath, Sebastien Taurin and Khaled Greish
Research Article: J Nanomed Nanotechnol 2014, 5:197
Babasaheb Yadav and Khaled Greish
Review Article: J Nanomed Nanotechnol 2011, S4-005
Khaled Greish, Katherine Muller, Julie IvanaJay and Don Haeng Lee
Research Article: J Nanomed Nanotechnol 2011, S4-004